학술논문
Preclinical rationale for targeting the PD‐1/PD‐L1 axis in combination with a CD38 antibody in multiple myeloma and other CD38‐ positive malignancies
Document Type
Article
Author
Source
In: Cancers . (Cancers, December 2020, 12(12):1-20)
Subject
Language
English
ISSN
20726694